<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: <z:hpo ids='HP_0002181'>Brain edema</z:hpo> is detrimental in <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> and its treatment options are limited </plain></SENT>
<SENT sid="1" pm="."><plain>Kinins are proinflammatory <z:chebi fb="7" ids="16670">peptides</z:chebi> that are released during tissue injury </plain></SENT>
<SENT sid="2" pm="."><plain>The effects of kinins are mediated by 2 different receptors (B1 and B2 receptor [B1R and B2R]) and comprise induction of <z:hpo ids='HP_0000969'>edema</z:hpo> formation and release of proinflammatory mediators </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> was induced in B1R knockout, B2R knockout, and <z:mp ids='MP_0002169'>wild-type</z:mp> mice by transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> volumes were measured by planimetry </plain></SENT>
<SENT sid="5" pm="."><plain>Evan's blue tracer was applied to determine the extent of <z:hpo ids='HP_0002181'>brain edema</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Postischemic <z:mp ids='MP_0001845'>inflammation</z:mp> was assessed by real-time reverse-transcriptase polymerase chain reaction and immunohistochemistry </plain></SENT>
<SENT sid="7" pm="."><plain>To analyze the effect of a pharmacological kinin receptor blockade, B1R and B2R inhibitors were injected </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: B1R knockout mice developed significantly smaller <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarctions</z:e> and less neurological deficits compared to <z:mp ids='MP_0002169'>wild-type</z:mp> controls (16.8+/-4.7 mm(3) vs 50.1+/-9.1 mm(3), respectively; P&lt;0.0001) </plain></SENT>
<SENT sid="9" pm="."><plain>This was accompanied by a dramatic reduction of <z:hpo ids='HP_0002181'>brain edema</z:hpo> and endothelin-1 expression, as well as less postischemic <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>Pharmacological blockade of B1R likewise salvaged ischemic tissue (15.0+/-9.5 mm(3) vs 50.1+/-9.1 mm(3), respectively; P&lt;0.01) in a dose-dependent manner, even when B1R inhibitor was applied 1 hour after transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>In contrast, B2R deficiency did not confer neuroprotection and had no effect on the development of tissue <z:hpo ids='HP_0000969'>edema</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: These data demonstrate that blocking of B1R can diminish <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> and <z:hpo ids='HP_0000969'>edema</z:hpo> formation in mice and may open new avenues for <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> treatment in humans </plain></SENT>
</text></document>